CAUTION: Keep out of reach of children
Presented for research literature review only Laisney V et al
The information here has been written in reference to Olympias NAD+ 100mg/mL injection only
The proportion of patients achieving NASH resolution in the absence of fibrosis progression was 40%, 36%, and 59% for the 0.1, 0.2, and 0.4 mg semaglutide arms, respectively, whereas the corresponding rate in the placebo arm was 17% (Newsome et al., 2021)
The new flavors are designed to be mixed, sipped and savored, perfect for high-fiber mocktails that naturally activate GLP-1, the satiety hormone that helps control appetite and cravings
We describe these shots as antioxidant and wellness support for healthy-looking skin, not as a skin-lightening treatment